Henric Bjarke
2019
In 2019, Henric Bjarke earned a total compensation of $590.8K as Senior Vice President and Chief Operating Officer at Inozyme Pharma.
Compensation breakdown
| Bonus | $99,201 |
|---|---|
| Option Awards | $141,388 |
| Salary | $350,200 |
| Total | $590,789 |
Bjarke received $350.2K in salary, accounting for 59% of the total pay in 2019.
Bjarke also received $99.2K in bonus and $141.4K in option awards.
Rankings
In 2019, Henric Bjarke's compensation ranked 11,253rd out of 13,971 executives tracked by ExecPay. In other words, Bjarke earned more than 19.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,253 out of 13,971 | 20th |
Division Manufacturing | 4,556 out of 5,698 | 20th |
Major group Chemicals And Allied Products | 1,792 out of 2,197 | 18th |
Industry group Drugs | 1,541 out of 1,883 | 18th |
Industry Pharmaceutical Preparations | 1,141 out of 1,395 | 18th |
Source: SEC filing on April 27, 2021.
Bjarke's colleagues
We found one more compensation record of an executive who worked with Henric Bjarke at Inozyme Pharma in 2019.
2019
Axel Bolte
Inozyme Pharma